Avricore Health (AVCRF) Gains from Sales and Divestitures (2024)
Avricore Health (AVCRF) reported Gains from Sales and Divestitures of -$22930.8 for Q4 2024.
Avricore Health (AVCRF) Gains from Sales and Divestitures (2024) Analysis & Trends
Avricore Health (AVCRF) has 1 years of Gains from Sales and Divestitures data on file, last reported at -$22930.8 in Q4 2024.
- Gains from Sales and Divestitures for Q4 2024 came in at -$22930.8, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$22930.8 (changed N/A YoY), and the FY2024 annual result was -$23396.9, changed N/A from the prior year.
- Gains from Sales and Divestitures held at -$22930.8 in Q4 2024 per AVCRF's latest filing.
- Over five years, Gains from Sales and Divestitures peaked at -$22930.8 in Q4 2024 and troughed at -$22930.8 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Avricore Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -22,930.80 |
| Dec 31, 2024 | -22,930.80 |